Also trades as: BOT.AX (ASX) · $vol 0M
BXPHF OTC
Botanix Pharmaceuticals Limited
1W: +46.8%
1M: -4.8%
3M: +40.4%
YTD: -79.8%
1Y: -88.1%
3Y: -86.6%
5Y: -77.1%
$0.02
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$65M
+17.9% ▲
Capital Expenditures
$3
+100.0% ▲
5Y CAGR: -79.5%
Free Cash Flow
-$65M
+19.0% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+100.0% ▲
Net Change in Cash
-$25M
-74.9% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$13M | -$9M | -$14M | $0 | -$70M |
| Depreciation & Amort. | $143K | $110K | $0 | $0 | $0 |
| Stock-Based Comp. | $334K | $2M | $0 | $0 | $0 |
| Change in Working Capital | $2M | -$5M | -$661K | -$31M | -$8M |
| Other Non-Cash Items | $334K | $2M | $6M | -$48M | $14M |
| Operating Cash Flow | -$11M | -$12M | -$8M | -$79M | -$65M |
| — Investing Activities — | |||||
| Capital Expenditures | -$3M | -$7M | -$113K | -$286K | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | -$18M | -$763K | -$408K |
| Investing Cash Flow | -$3M | -$7M | -$18M | -$1M | -$408K |
| — Financing Activities — | |||||
| Net Debt Issuance | -$152K | -$122K | $0 | $28M | -$5M |
| Stock Repurchased | $0 | $0 | -$6M | -$3M | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $0 | $0 | -$193K | -$265K |
| Financing Cash Flow | -$152K | $22M | $95M | $65M | $37M |
| Net Change in Cash | -$14M | $3M | $69M | -$14M | -$25M |
| Cash End of Period | $7M | $10M | $79M | $65M | $37M |
| Free Cash Flow | -$14M | -$19M | -$26M | -$80M | -$65M |